Compare BLCO & VSEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLCO | VSEC |
|---|---|---|
| Founded | 1853 | 1959 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Military/Government/Technical |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 5.1B |
| IPO Year | 2022 | 1995 |
| Metric | BLCO | VSEC |
|---|---|---|
| Price | $16.41 | $194.49 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 7 |
| Target Price | $18.55 | ★ $230.71 |
| AVG Volume (30 Days) | 452.1K | ★ 493.8K |
| Earning Date | 01-01-0001 | 05-28-2026 |
| Dividend Yield | N/A | ★ 0.21% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.55 |
| Revenue | ★ $5,101,000,000.00 | $760,113,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.52 | $25.30 |
| P/E Ratio | ★ N/A | $352.78 |
| Revenue Growth | 6.47 | ★ 9.88 |
| 52 Week Low | $10.45 | $100.53 |
| 52 Week High | $18.92 | $231.60 |
| Indicator | BLCO | VSEC |
|---|---|---|
| Relative Strength Index (RSI) | 37.97 | 38.94 |
| Support Level | $16.35 | $158.16 |
| Resistance Level | $16.81 | $228.30 |
| Average True Range (ATR) | 0.51 | 10.78 |
| MACD | -0.22 | -3.62 |
| Stochastic Oscillator | 9.80 | 6.67 |
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
VSE Corp is a diversified aftermarket products and services company providing repair services, parts distribution, logistics, supply chain management, and consulting services for land, sea, and air transportation assets to commercial and government markets. Its operations include supply chain management solutions, parts supply and distribution, and maintenance, repair, and overhaul (MRO) services for vehicle fleet, aviation, maritime and other customers. Its reportable segments are; Aviation and Fleet. The majority of the revenue for the company is generated from the Aviation segment which is a provider of aftermarket parts distribution and MRO services for components and engine accessories supporting commercial, business, and general aviation operators.